These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1615182)

  • 1. Effect of bromhexeine on sputum amoxycillin levels in lower respiratory infections.
    Taskar VS; Sharma RR; Goswami R; John PJ; Mahashur AA
    Respir Med; 1992 Mar; 86(2):157-60. PubMed ID: 1615182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of lower respiratory tract infections with amoxycillin/clavulanic acid in adults.
    Tatsis G; Veslemes M; Hadjistavrou C; Votsiou A; Jordanoglou J
    J Int Med Res; 1993; 21(2):98-101. PubMed ID: 8243795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefuroxime and cefuroxime axetil versus amoxicillin plus clavulanic acid in the treatment of lower respiratory tract infections.
    Brambilla C; Kastanakis S; Knight S; Cunningham K
    Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):118-24. PubMed ID: 1396725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of a fluidifying agent (bromhexine) on the penetration of antibiotics into respiratory secretions.
    Bergogne-Bérézin E; Berthelot G; Kafé HP; Dournovo P
    Int J Clin Pharmacol Res; 1985; 5(5):341-4. PubMed ID: 4066084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical effectiveness of a combination of bromhexine and amoxicillin in lower respiratory tract infection. A randomized controlled trial.
    Roa CC; Dantes RB
    Arzneimittelforschung; 1995 Mar; 45(3):267-72. PubMed ID: 7741782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of erdosteine, a mucolytic agent, on amoxycillin penetration into sputum in patients with an infective exacerbation of chronic bronchitis.
    Ricevuti G; Mazzone A; Uccelli E; Gazzani G; Fregnan GB
    Thorax; 1988 Aug; 43(8):585-90. PubMed ID: 3051508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind randomized study of prolonged higher-dose oral amoxycillin in purulent bronchiectasis.
    Currie DC; Garbett ND; Chan KL; Higgs E; Todd H; Chadwick MV; Gaya H; Nunn AJ; Darbyshire JH; Cole PJ
    Q J Med; 1990 Aug; 76(280):799-816. PubMed ID: 2217684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ofloxacin compared with amoxycillin in treating infective exacerbations in bronchiectasis.
    Lam WK; Chau PY; So SY; Leung YK; Chan JC; Ip M; Sham MK
    Respir Med; 1989 Jul; 83(4):299-303. PubMed ID: 2692094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of bromhexine in exacerbations of bronchiectasis. Double-blind randomized multicenter study versus placebo.
    Olivieri D; Ciaccia A; Marangio E; Marsico S; Todisco T; Del Vita M
    Respiration; 1991; 58(3-4):117-21. PubMed ID: 1745841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azithromycin for acute lower respiratory tract infections.
    Panpanich R; Lerttrakarnnon P; Laopaiboon M
    Cochrane Database Syst Rev; 2004 Oct; (4):CD001954. PubMed ID: 15497172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind comparison of the effects of cefaclor and amoxycillin on respiratory tract and oropharyngeal flora and clinical response in acute exacerbations of bronchitis.
    Trigg CJ; Wilks M; Herdman MJ; Clague JE; Tabaqchali S; Davies RJ
    Respir Med; 1991 Jul; 85(4):301-8. PubMed ID: 1947367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of oral ciprofloxacin and amoxycillin in treating infective exacerbations of bronchiectasis in Hong Kong.
    Chan TH; Ho SS; Lai CK; Cheung SW; Chan RC; Cheng AF; Chan CH
    Chemotherapy; 1996; 42(2):150-6. PubMed ID: 8697891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective comparison of ampicillin and amoxycillin in chest infections.
    Wood JB; Alexander AM
    Br J Dis Chest; 1982 Jul; 76(3):234-6. PubMed ID: 7126436
    [No Abstract]   [Full Text] [Related]  

  • 14. Sputum and serum levels of amoxycillin in chronic bronchial infections.
    Ingold A
    Br J Dis Chest; 1975 Jul; 69():211-6. PubMed ID: 1201187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a short course of clarithromycin therapy on sputum production in patients with chronic airway hypersecretion.
    Tagaya E; Tamaoki J; Kondo M; Nagai A
    Chest; 2002 Jul; 122(1):213-8. PubMed ID: 12114361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of beta-lactamases in the response of pulmonary infections to amoxycillin/clavulanate.
    Stockley RA; Dragicevic P; Burnett D; Hill SL
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():73-81. PubMed ID: 2606821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythromycin and bromhexine in acute exacerbations of chronic bronchitis. A study on sputum penetration and clinical effectiveness.
    Maesen FP; Davies BI; Brouwers J; Rubingh G
    Eur J Respir Dis; 1982 Jul; 63(4):325-9. PubMed ID: 6981522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of probenecid to increase the serum amoxycillin levels in patients with bronchiectasis.
    Allen MB; Fitzpatrick RW; Barratt A; Cole RB
    Respir Med; 1990 Mar; 84(2):143-6. PubMed ID: 2371437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefaclor and amoxycillin in the treatment of infective exacerbations of chronic bronchitis.
    Law MR; Holt HA; Reeves DS; Hodson ME
    J Antimicrob Chemother; 1983 Jan; 11(1):83-8. PubMed ID: 6337988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ambroxol plus amoxicillin in the treatment of exacerbations of chronic bronchitis.
    Peralta J; Poderoso JJ; Corazza C; Fernández M; Guerreiro RB; Wiemeyer JC
    Arzneimittelforschung; 1987 Aug; 37(8):969-71. PubMed ID: 3675696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.